Discover millions of ebooks, audiobooks, and so much more with a free trial

Only $11.99/month after trial. Cancel anytime.

Explore The Future of Health™ with Outcomes Rocket
Explore The Future of Health™ with Outcomes Rocket
Explore The Future of Health™ with Outcomes Rocket
Ebook72 pages1 hour

Explore The Future of Health™ with Outcomes Rocket

Rating: 0 out of 5 stars

()

Read preview

About this ebook

Dive into Deloitte's vision for The Future of Health to discover how to transform your organization meet the demands of today's health care consumers. The Moment is Now.

LanguageEnglish
Release dateJan 18, 2024
ISBN9798224424719
Explore The Future of Health™ with Outcomes Rocket

Related to Explore The Future of Health™ with Outcomes Rocket

Related ebooks

Medical For You

View More

Related articles

Reviews for Explore The Future of Health™ with Outcomes Rocket

Rating: 0 out of 5 stars
0 ratings

0 ratings0 reviews

What did you think?

Tap to rate

Review must be at least 10 words

    Book preview

    Explore The Future of Health™ with Outcomes Rocket - Neal Batra

    PROLOGUE

    Simon Gisby: The Future of Health. In this audiobook, Saul Marquez host of Outcomes Rocket interviews Deloitte Thought leaders Neal Batra, Andy Davis, Simon Gisby, Boris Kheyn-Kheyfets, and Jen Radin on the key drivers setting the stage for the Future of Health. Copyright 2023 by Deloitte and Outcomes Rocket.

    Saul Marquez: All right. Welcome to the Future of Health audiobook. I am so excited to be here with an extraordinary team from Deloitte. Just by way of introduction, they will be the ones that you hear on this audiobook telling the Future of Health. Simon Gisby, Boris Kheyn-Kheyfets, Neal Batra, Andrew Davis, and Jen Radin. So excited that you guys are all here with us. Let's talk a little bit about the origins of the Future of Health in 2017. How did it all begin?

    Neal Batra: Yeah, so it's a funny story. What ended up playing out was we were seeing a whole bunch of non-intuitive action in the marketplace. Big pharma buying a big data company, the emergence of some retail health considerations that were kind of on the fringe, chat of retailers buying large players, which ultimately played out with one of the majors. And we know that story. And so, what we really lacked was a unifying narrative, which is what is going on here. Is this an extension and a blip, or is this a fundamental pivot and shift? And do we really have a point of view that we can articulate at the board level, at the C-suite level, and frankly, through our eminence in a consistent way? And so that was the genesis of, Hey, we need to really understand what's happening, because, frankly, we don't really have a great sense for what this moment actually is.

    Saul Marquez: That's great, Neal. And so really thinking about how the market responded when Deloitte first shared this vision, what were some of the reactions?

    Simon Gisby: It was very positive. Because you've also got to remember back in 2017 and still to today, there's huge concern about escalating cost of health care in the US, the increasing percent of GDP it's taking up. And the variability in outcomes and the

    huge disparity in health equity. So that was also a foundational platform or thought process. But when we took it to market and we went out to a whole variety of different customers, organizations, stakeholders, big cap pharma, medtech, health systems, plans, government agencies. The first thing we were surprised at was the transformation was going to happen faster than we anticipated. The fundamental dynamics were in place and the acceleration was occurring faster than we felt comfortable predicting. So, we had Future of Health 2040. And remember, a major world-class health system said, no guys, it's 2030. Play catch up. So, I think that was the first takeaway. The second one was a recognition that the reimbursement model had to play catch up in accelerating some of this change. And the third one was a pretty healthy debate about are the regulators going to be an impediment or a catalyst. And I, for one, think the regulators have been the catalyst in some of these changes. So that was also a bit of a surprise because you don't normally think of regulators as being at the forefront of transformational change, but think what's happening in the health care industry is they're certainly doing this.

    Jen Radin: When we first came out with the Future of Health and the vision, that again, we were really thinking 2040. Some of the stakeholders in the market were very interested in this point of view and accepting of it, but others not as much. I really understand that if you are a health care delivery organization, you're a true incumbent in this model, or even a national health plan, and you may not be as interested or willing and hearing, looking at archetypes, that really disintermediate an entire system of care that you've put together. So, some of the reactions were interested and wanted to talk more about it. And some of them, I would say were somewhat negative and not surprisingly so.

    Andrew Davis: One thing to add, if you don't mind, on top of that is I think what we saw too, especially as the narrative first got rolled out, you had those that embraced it, saw the transformation, just like you were saying that it's moving faster and we should expect it to happen faster. And then you had a cohort that would call, put in the resisting bucket like, no, the model exists and we'll be fine. And but this transformation can never happen. You require clinical care the way it's delivered today. And that resistance, I would say early in the narrative, we've started to see move down to something that's really small. As we have that narrative today, it's like I think everyone has seen the transformation. But early on you saw this polarization of belief or resistance and I think a lot of the resistance now has gone away.

    Simon Gisby: Yeah. And Andrew, what I find fascinating about that is. We've all been in for years, right? There was always this knee-jerk reaction of but health care is different. As an industry, as a sector, we're just different, right? And if you look at Future of Health, you started challenging people going, are we really that different from other sectors? Is consumer behavior really that different? Right?. Why should we always be in the mindset of we're unique and different and we can't adapt and change and transform when in every other part of our lives we're embracing data, we're embracing consumer preference, we're embracing engagement, and found that fascinating, right? And then Saul, to be honest, the pandemic accelerated it.

    Saul Marquez: Absolutely. 

    Simon Gisby: Right? We had this all of a sudden, the pandemic. I think the entire economy realized their health care economy, right? A health care situation transformed the economy. And now all those things that we

    Enjoying the preview?
    Page 1 of 1